Hinge Health Inc.
HNGE Healthcare Health Information Services
Hinge Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $587.9 million, up 50.6% from fiscal 2024.
- Revenue
- +53.0%
- EPS
- +104.2%
- Free cash flow
- +441.1%
Quarter to June 2026, against a year earlier
Follow HNGE
Alert me
Hinge Health Inc. (HNGE) EV/FCF
As of 6 November 2026, Hinge Health Inc. (HNGE) trades at a EV/FCF of 30.8×. Over the past ten years it has ranged from 1.3× (June 2025) to 32.2× (November 2026); the current reading is higher than 99% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 13.1× | 534.68% |
| FY2024 | 2.1× | 0.00% |
| FY2023 | 2.1× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 21.7× | 62.12% |
| Mar 2026 | 13.4× | 2.01% |
| Dec 2025 | 13.1× | (45.21%) |
| Sep 2025 | 24.0× | 12.03% |
| 4 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| TEM Tempus AI, Inc. compare | −89.6× |
| HTFL Heartflow, Inc. compare | −76.6× |
| SDGR Schrodinger, Inc. compare | −15.4× |
| DOCS Doximity, Inc. compare | 17.7× |
| HQY HealthEquity, Inc. compare | 21.2× |
| PRVA Privia Health Group, Inc. compare | 24.3× |
| WAY Waystar Holding Corp. compare | 25.3× |
| BTSG BrightSpring Health Services, Inc. compare | 30.7× |
| HNGE Hinge Health Inc. | 30.9× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on HNGE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement